Dr. Bednar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2100 Wescott Dr
Flemington, NJ 08822Phone+1 908-788-6461
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1997 - 2000- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1995 - 1997
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 1994 - 1995- Icahn School of Medicine at Mount SinaiInternship, Transitional Year, 1993 - 1994
Rutgers Robert Wood Johnson Medical SchoolClass of 1993
Certifications & Licensure
NJ State Medical License 1995 - 2025
NY State Medical License 1995 - 2000- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 9 citations13-cis Retinoic Acid and Complete Androgen Blockade in Advanced Hormone-Naive Prostate Cancer Patients: Report of a Phase II Randomized StudyAnna C. Ferrari, Nelson N. Stone, Richard G. Stock, Myron Bednar, Isaac Esseesse
Journal of Clinical Oncology. 2002-01-15 - 23 citationsA Phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinoma.Anna C. Ferrari, Abraham Chachoua, Harvinder Singh, M. Rosenthal, Samir Taneja
Cancer. 2001-06-01
Press Mentions
Five Physicians of Hunterdon Hematology Oncology Named NJ Top Docs for 2022October 20th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
